Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma
- PMID: 18776818
- DOI: 10.1097/INF.0b013e318175d85c
Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma
Abstract
A 21-month-old girl with neuroblastoma developed chronic verrucous Oka strain varicella-zoster infection during chemotherapy. Virus isolated from the patient demonstrated high-level acyclovir resistance, and its thymidine kinase had no in vitro enzymatic activity. After foscarnet therapy, she underwent stem cell transplantation without varicella reactivation. This is only the second reported case of resistant varicella zoster virus caused by Oka strain virus.
Similar articles
-
Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child.J Infect Dis. 2003 Oct 1;188(7):954-9. doi: 10.1086/378502. Epub 2003 Sep 26. J Infect Dis. 2003. PMID: 14513413
-
Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature.Pediatr Infect Dis J. 2008 Jan;27(1):75-7. doi: 10.1097/INF.0b013e3181598315. Pediatr Infect Dis J. 2008. PMID: 18162946 Review.
-
Herpes zoster due to Oka vaccine strain of varicella zoster virus in an immunosuppressed child post cord blood transplant.J Paediatr Child Health. 2007 Oct;43(10):713-5. doi: 10.1111/j.1440-1754.2007.01191.x. J Paediatr Child Health. 2007. PMID: 17854459
-
[Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].Ann Biol Clin (Paris). 2003 Jan-Feb;61(1):33-40. Ann Biol Clin (Paris). 2003. PMID: 12604384 Review. French.
-
Clinicopathologic understanding and control of varicella-zoster virus infection.Vaccine. 2008 Nov 25;26(50):6487-90. doi: 10.1016/j.vaccine.2008.08.004. Epub 2008 Aug 9. Vaccine. 2008. PMID: 18694794 Review.
Cited by
-
Pathogenesis and current approaches to control of varicella-zoster virus infections.Clin Microbiol Rev. 2013 Oct;26(4):728-43. doi: 10.1128/CMR.00052-13. Clin Microbiol Rev. 2013. PMID: 24092852 Free PMC article. Review.
-
The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA.J Virol. 2014 Jul;88(14):7973-86. doi: 10.1128/JVI.00376-14. Epub 2014 May 7. J Virol. 2014. PMID: 24807720 Free PMC article.
-
A Toddler With Rash, Encephalopathy, and Hemolytic Anemia.J Pediatric Infect Dis Soc. 2015 Dec;4(4):376-80. doi: 10.1093/jpids/piv032. Epub 2015 May 28. J Pediatric Infect Dis Soc. 2015. PMID: 26407265 Free PMC article. No abstract available.
-
Disseminated vaccine-strain varicella-zoster virus reactivation in an adolescent with secondary immunodeficiency: a case report and literature review.BMC Infect Dis. 2024 Nov 14;24(1):1296. doi: 10.1186/s12879-024-09776-1. BMC Infect Dis. 2024. PMID: 39543470 Free PMC article. Review.
-
Vaccine Oka Varicella Meningitis in Two Adolescents.Pediatrics. 2019 Dec;144(6):e20191522. doi: 10.1542/peds.2019-1522. Pediatrics. 2019. PMID: 31776194 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical